Drugmaker to sell cheaper generic rival to EpiPen injectors

A generic drugmaker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

Posted: Dec 6, 2018 4:34 PM

TRENTON, N.J. (AP) — A generic drugmaker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

The penlike injectors are used to treat life-threatening allergic reactions. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.

Drugmaker Sandoz said Thursday the price of two generic injectors will be $250 without insurance. Two other generics on the market in the U.S. cost $300 a pair. Brand-name EpiPens sold by Mylan cost at least twice as much.

The price people pay varies, though, depending on insurance and discounts.

Mylan was blasted in the past for price hikes that pushed the price over $600. It responded by selling its own generic.

Article Comments

Terre Haute
Few Clouds
74° wxIcon
Hi: 81° Lo: 64°
Feels Like: 74°
Robinson
Broken Clouds
71° wxIcon
Hi: 78° Lo: 63°
Feels Like: 71°
Indianapolis
Broken Clouds
75° wxIcon
Hi: 76° Lo: 62°
Feels Like: 75°
Rockville
Few Clouds
74° wxIcon
Hi: 81° Lo: 61°
Feels Like: 74°
Casey
Clear
73° wxIcon
Hi: 79° Lo: 63°
Feels Like: 73°
Brazil
Few Clouds
74° wxIcon
Hi: 79° Lo: 63°
Feels Like: 74°
Marshall
Few Clouds
74° wxIcon
Hi: 79° Lo: 62°
Feels Like: 74°
Scattered showers before a cool off
WTHI Planner
WTHI Temps
WTHI Radar

WTHI Events